Karuna Pharmaceuticals

Karuna Pharmaceuticals

Karuna Pharmaceuticals

Karuna Pharmaceuticals is a Massachusetts-based developer of drugs for the treatment of schizophrenia.
Raised
$42M
Follow us
Alexa global traffic share
Latest funding
$42,000,000
Venture capital (Series A) - 2018
ARCH Venture Partners Wellcome Trust PureTech Health +1
Team Size
1–10
Employees
FinSMEs

Karuna Pharmaceuticals Closes $42M Series A Financing Round

Health Science Funding
$42,000,000 Venture capital (Series A)
MedCity News

Karuna Pharmaceuticals raises $42 million in Series A funding round